|
|
|
Volumn 69, Issue 6, 2004, Pages 1558-1560
|
|
ACOG Releases Guidelines for Clinical Management of Osteoporosis
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALENDRONIC ACID;
BISPHOSPHONIC ACID DERIVATIVE;
CALCITONIN;
ESTROGEN;
PARATHYROID HORMONE;
RALOXIFENE;
RISEDRONIC ACID;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
TAMOXIFEN;
TIBOLONE;
BONE DENSITY;
BONE MINERAL;
DRUG EFFICACY;
DRUG SAFETY;
DUAL ENERGY X RAY ABSORPTIOMETRY;
FEMALE;
FRAGILITY FRACTURE;
GASTROINTESTINAL SYMPTOM;
HUMAN;
LIFESTYLE;
OSTEOLYSIS;
OSTEOPOROSIS;
POSTMENOPAUSE;
PRACTICE GUIDELINE;
REVIEW;
RISK ASSESSMENT;
RISK FACTOR;
SCREENING;
SIDE EFFECT;
VASOMOTOR DISORDER;
VENOUS THROMBOEMBOLISM;
BONE DENSITY;
ESTROGEN REPLACEMENT THERAPY;
FEMALE;
HUMANS;
LIFE STYLE;
MASS SCREENING;
OSTEOPOROSIS, POSTMENOPAUSAL;
PRACTICE GUIDELINES;
RISK ASSESSMENT;
UNITED STATES;
|
|
EID: 1642277865
PISSN: 0002838X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (12)
|
|
References (0)
|